Global Markets

- Advertisement -
Ad image

Latest Global Markets News

Lesotho insulted after Trump says no person has heard of the nation

Lesotho insulted after Trump says no person has heard of the nation

StockWaves StockWaves

CRWD Earnings: A snapshot of CrowdStrike’s This autumn 2025 report

Cybersecurity firm CrowdStrike Holdings, Inc. (NASDAQ: CRWD) reported a rise in adjusted revenue for the fourth quarter of 2025, reflecting…

StockWaves StockWaves

An investor who put £10,000 into BAE Methods shares at the beginning of the yr would have already got…

Picture supply: Getty Pictures It’s been an unimaginable begin to the yr for BAE Methods (LSE: BA) shares. That’s excellent…

StockWaves StockWaves

WonderFi Applied sciences indicators LOI with Eightcap to supply multi-asset buying and selling

WonderFi Applied sciences (TSX:WNDR:CA) on Wednesday entered right into a non-binding Letter of Intent ("LOI") to type a brand new…

StockWaves StockWaves

China says it is able to struggle any sort of warfare U.S. desires ‘until the top’

Canada appeals to WTO over U.S. tariffsCanada has appealed to the World Commerce Group over the imposition of tariffs by…

StockWaves StockWaves

Evaluation-Spending U-turn places Germany again in Europe's driving seat

Evaluation-Spending U-turn places Germany again in Europe's driving seat

StockWaves StockWaves

A FTSE 100 share and an ETF for cautious buyers to think about in March!

Picture supply: Getty Pictures Researching stable shares to purchase in unsure occasions? Right here’s a FTSE 100 share and an…

StockWaves StockWaves

Full Truck Alliance beats top-line and bottom-line estimates; initiates Q1 outlook

Full Truck Alliance beats top-line and bottom-line estimates; initiates Q1 outlook

StockWaves StockWaves

Qualcomm CEO says its new modem creates a ‘enormous delta’ with Apple

Apple webpage with iPhone 16e advert is screened on a cell phone for illustration picture. Beata Zawrzel | Nurphoto | Getty…

StockWaves StockWaves

Sandoz posts regular FY24 outcomes, cautious FY25 outlook, Biosimilars in focus

Sandoz posts regular FY24 outcomes, cautious FY25 outlook, Biosimilars in focus

StockWaves StockWaves